-
Nearly 3,200 pairs of U.S. approved generic and brand drug names look or sound enough alike that health care workers mix up the medications. That's the finding of new research from the United States Pharmacopeia (USP), which reviewed more than 26,000 records in two USP-associated medication error reporting programs for 2003-2006.
-
Tumor lysis syndrome (TLS) is a serious and life-threatening complication that is frequently seen following initiation of chemotherapy.
-
FDA recently announced these approvals: FDA approved Medtronic's Endeavor® Zotarolimus-Eluting Coronary Stent for use in treating patients with narrowed coronary arteries.
-
-
If you serve on your hospital's ethics committee, does that make you a medical ethicist?
-
It's the ethical spectre that emerges with every advance in genetic testing. Should children be tested for gene mutations that predispose them to developing serious illnesses later in life?
-
Clinical research teams and investigators may find that their traditional strategies for handling incidental findings during a trial are inadequate in this age of genetic research.
-
Calls to legalize marijuana for medical use have come from an assortment of groups, but none with the status and influence of the American College of Physicians (ACP), the country's second-largest medical association, until now.
-
Lots has been written about physicians' unwillingness to report medical errors, but findings from the federal Agency for Healthcare Research and Quality (AHRQ) suggest it's not a lack of honesty and ethics at work it's a lack of confidence in current reporting systems.
-
Placebos have been a part of medicine since ancient times, and remain both clinically relevant and philosophically interesting, according to a University of Chicago medical student whose research has shown that 45% of Chicago-area internists use placebos in their practice.
